Braun Stacey Associates Inc. Buys 5,398 Shares of CME Group Inc. $CME

Posted by Francis Steltz on Aug 29th, 2026

Braun Stacey Associates Inc. lifted its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 4.8% during the second quarter, Holdings Channel.com reports. The firm owned 117,163 shares of the financial services provider’s stock after buying an additional 5,398 shares during the quarter. Braun Stacey Associates Inc.’s holdings in CME Group were worth $25,873,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Whipplewood Advisors LLC increased its holdings in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares during the period. Elkhorn Partners Limited Partnership acquired a new position in shares of CME Group during the 4th quarter worth $27,000. Hilton Head Capital Partners LLC acquired a new position in CME Group during the fourth quarter worth about $28,000. Legacy Wealth Managment LLC ID increased its position in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares in the last quarter. Finally, Main Street Group LTD acquired a new position in shares of CME Group during the first quarter worth $32,000. 87.75% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of CME Group from a “strong sell” rating to a “sell” rating in a report on Saturday. JPMorgan Chase & Co. lifted their price objective on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research report on Thursday, July 23rd. UBS Group dropped their target price on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research report on Monday, July 6th. Piper Sandler dropped their price target on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 15th. Finally, Weiss Ratings downgraded shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus price target of $288.56.

Read Our Latest Stock Analysis on CME Group

CME Group Stock Performance

Shares of CME Group stock opened at $285.80 on Friday. The firm has a market capitalization of $102.77 billion, a P/E ratio of 24.24, a price-to-earnings-growth ratio of 3.34 and a beta of 0.23. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The business’s fifty day simple moving average is $253.80 and its 200 day simple moving average is $279.13.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.96 earnings per share. As a group, analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio is currently 44.11%.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction on Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.